000 01427 a2200385 4500
005 20250513170906.0
264 0 _c19990329
008 199903s 0 0 eng d
022 _a1521-6616
024 7 _a10.1006/clim.1998.4624
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHildreth, J E
245 0 0 _aAntibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
_h[electronic resource]
260 _bClinical immunology (Orlando, Fla.)
_cFeb 1999
300 _a203-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntibody-Dependent Cell Cytotoxicity
650 0 4 _aDNA, Viral
_xanalysis
650 0 4 _aHIV Antibodies
_xmetabolism
650 0 4 _aHIV Infections
_ximmunology
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHaptens
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xmetabolism
650 0 4 _aIn Vitro Techniques
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLeukocytes, Mononuclear
_ximmunology
650 0 4 _aNeutralization Tests
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTrinitrobenzenes
_ximmunology
700 1 _aHampton, R
700 1 _aHalsey, N A
773 0 _tClinical immunology (Orlando, Fla.)
_gvol. 90
_gno. 2
_gp. 203-12
856 4 0 _uhttps://doi.org/10.1006/clim.1998.4624
_zAvailable from publisher's website
999 _c10040626
_d10040626